Tech Company Financing Transactions
Arranta Bio Funding Round
Arranta Bio closed a $82 million financing round on 10/31/2019. Backers included Ampersand Capital Partners, Thermo Fisher Scientific and private investors.
Transaction Overview
Company Name
Announced On
10/31/2019
Transaction Type
Venture Equity
Amount
$82,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
650 Pleasant St.
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Undisclosed
Website
Email Address
Overview
Arranta Bio is delivering on its vision to build the best-in-class microbiome contract development and manufacturing organization (CDMO) through the establishment of a facility dedicated to process development and cGMP clinical supply with a commercial-ready capability.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Bamforth
Founder
Iain Baird
Browse more venture capital transactions:
Prev: 10/31/2019: Ruti venture capital transaction
Next: 10/31/2019: Duality Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs